Miltefosine (CAS 58066-85-6) – Antiprotozoal API

Miltefosine (CAS 58066-85-6) is a high-potency antiprotozoal API with a unique alkylphosphocholine structure, exhibiting broad-spectrum activity against protozoan pathogens. Its core mechanism disrupts the lipid metabolism and cell membrane integrity of target parasites, inhibiting their proliferation and inducing cell death. Produced under strict GMP-certified processes, it ensures exceptional purity, consistent bioactivity, and compliance with international pharmaceutical standards for anti-infective drugs.

This premium API is a critical raw material for pharmaceutical manufacturers developing treatments for neglected tropical diseases. It is widely applied in formulating oral medications for visceral leishmaniasis, cutaneous leishmaniasis, and amoebic dysentery, especially for cases resistant to traditional therapies. With proven clinical efficacy and oral bioavailability, it addresses the urgent global demand for accessible antiprotozoal treatments. For pharmaceutical R&D teams and production enterprises, it provides a trusted solution to advance therapies for protozoan infections.